Global Atherectomy and Thrombectomy Devices Market 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Atherectomy Products
03.2.2 Thrombectomy Products
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Global Atherectomy and Thrombectomy Devices Market
06.1 Market Overview
06.1.1 Market Size and Forecast
07. Global Atherectomy and Thrombectomy Market Segmentation by Product Type
07.1 Atherectomy Devices
07.2 Thrombectomy Devices
07.3 Five Forces Analysis
08. Global Atherectomy Devices Market
08.1 Market Overview
08.1.1 Market Size and Forecast
08.2 Market Segmentation by Procedure Type
09. Global Thrombectomy Devices Market
09.1 Market Overview
09.1.1 Market Size and Forecast
09.2 Market Segmentation by Product Type
09.3 Market Segmentation by Procedure Type
10. Reimbursement Scenario of Atherectomy and Thrombectomy Devices
10.1 Reimbursement Scenario in Americas
10.2 Reimbursement Scenario in EMEA
10.3 Reimbursement Scenario in APAC
11. Geographical Segmentation
11.1 Atherectomy and Thrombectomy Devices Market in the Americas
11.1.1 Market Size and Forecast
11.2 Atherectomy and Thrombectomy Devices Market in EMEA
11.2.1 Market Size and Forecast
11.3 Atherectomy and Thrombectomy Devices Market in APAC
11.3.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Boston Scientific
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Business Segmentation by Revenue
20.1.6 Business Segmentation by Revenue 2012 and 2013
20.1.7 Geographical Segmentation by Revenue
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Cardiovascular Systems
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Product Segmentation Based on Therapy Areas
20.2.4 Business Strategy
20.2.5 Recent Developments
20.2.6 SWOT Analysis
20.3 Medtronic
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation
20.3.4 Revenue by Business Segmentation
20.3.5 Revenue Comparison by Business Segmentation 2012 and 2013
20.3.6 Revenue by Geographical Segmentation
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Spectranetics
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation 2014
20.4.4 Business Segmentation by Revenue 2013 and 2014
20.4.5 Geographical Segmentation by Revenue 2014
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis
21. Other Reports in this Series